Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI:10.1093/annonc/mdu390

J. C. Soria; F. Debraud; R. Bahleda; B. Adamo; F. Andre; R. Dienstmann; A. Delmonte; R. Cereda; J. Isaacson; J. Litten; A. Allen; F. Dubois; C. Saba; R. Robert; M. D'incalci; M. Zucchetti; M. G. Camboni; J. Tabernero

doi:10.1093/annonc/mdu547

Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI:10.1093/annonc/mdu390

J. C. Soria, F. Debraud, R. Bahleda, B. Adamo, F. Andre, R. Dienstmann, A. Delmonte, R. Cereda, J. Isaacson, J. Litten, A. Allen, F. Dubois, C. Saba, R. Robert, M. D'incalci, M. Zucchetti, M. G. Camboni, J. Tabernero

Résultats de recherche: Contribution à un journal › !!Comment/debate

1 Citation (Scopus)

langue originale	Anglais
Pages (de - à)	445
Nombre de pages	1
journal	Annals of Oncology
Volume	26
Numéro de publication	2
Les DOIs	https://doi.org/10.1093/annonc/mdu547
état	Publié - 1 févr. 2015

Accès au document

10.1093/annonc/mdu547

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Soria, J. C., Debraud, F., Bahleda, R., Adamo, B., Andre, F., Dienstmann, R., Delmonte, A., Cereda, R., Isaacson, J., Litten, J., Allen, A., Dubois, F., Saba, C., Robert, R., D'incalci, M., Zucchetti, M., Camboni, M. G., & Tabernero, J. (2015). Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI:10.1093/annonc/mdu390. Annals of Oncology, 26(2), 445. https://doi.org/10.1093/annonc/mdu547

@article{4ad366474b3f4d5a8eb630371a271b66,

title = "Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI:10.1093/annonc/mdu390",

author = "Soria, {J. C.} and F. Debraud and R. Bahleda and B. Adamo and F. Andre and R. Dienstmann and A. Delmonte and R. Cereda and J. Isaacson and J. Litten and A. Allen and F. Dubois and C. Saba and R. Robert and M. D'incalci and M. Zucchetti and Camboni, {M. G.} and J. Tabernero",

year = "2015",

month = feb,

day = "1",

doi = "10.1093/annonc/mdu547",

language = "English",

volume = "26",

pages = "445",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "2",

}

Soria, JC, Debraud, F, Bahleda, R, Adamo, B, Andre, F, Dienstmann, R, Delmonte, A, Cereda, R, Isaacson, J, Litten, J, Allen, A, Dubois, F, Saba, C, Robert, R, D'incalci, M, Zucchetti, M, Camboni, MG & Tabernero, J 2015, 'Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI:10.1093/annonc/mdu390', Annals of Oncology, VOL. 26, Numéro 2, p. 445. https://doi.org/10.1093/annonc/mdu547

Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI:10.1093/annonc/mdu390. / Soria, J. C.; Debraud, F.; Bahleda, R. et al.
Dans: Annals of Oncology, Vol 26, Numéro 2, 01.02.2015, p. 445.

Résultats de recherche: Contribution à un journal › !!Comment/debate

TY - JOUR

T1 - Corrigenda to Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors [Ann Oncol, 25 (2014) 2244-2251] DOI:10.1093/annonc/mdu390

AU - Soria, J. C.

AU - Debraud, F.

AU - Bahleda, R.

AU - Adamo, B.

AU - Andre, F.

AU - Dienstmann, R.

AU - Delmonte, A.

AU - Cereda, R.

AU - Isaacson, J.

AU - Litten, J.

AU - Allen, A.

AU - Dubois, F.

AU - Saba, C.

AU - Robert, R.

AU - D'incalci, M.

AU - Zucchetti, M.

AU - Camboni, M. G.

AU - Tabernero, J.

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84925301725&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdu547

DO - 10.1093/annonc/mdu547

M3 - Comment/debate

AN - SCOPUS:84925301725

SN - 0923-7534

VL - 26

SP - 445

JO - Annals of Oncology

JF - Annals of Oncology

IS - 2

ER -